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Background: Nutritionists advise pregnant women to eat fish to obtain adequate docosahexaenoic acid (DHA), an
essential nutrient important for optimal brain development. However, concern exists that this advice will lead to
excess intake of methylmercury, a developmental neurotoxicant.
Objective: Conduct a pilot intervention to increase consumption of high-DHA, low-mercury fish in pregnancy.
Methods: In April-October 2010 we recruited 61 women in the greater Boston, MA area at 12–22 weeks gestation
who consumed <=2 fish servings/month, and obtained outcome data from 55. We randomized participants to 3
arms: Advice to consume low-mercury/high-DHA fish (n=18); Advice + grocery store gift cards (GC) to purchase fish
(n=17); or Control messages (n=20). At baseline and 12-week follow-up we estimated intake of fish, DHA and
mercury using a 1-month fish intake food frequency questionnaire, and measured plasma DHA and blood and hair
total mercury.
Results: Baseline characteristics and mean (range) intakes of fish [21 (0–125) g/day] and DHA from fish [91 (0–554)
mg/d] were similar in all 3 arms. From baseline to follow-up, intake of fish [Advice: 12 g/day (95% CI: -5, 29),
Advice+GC: 22 g/day (5, 39)] and DHA [Advice: 70 mg/d (3, 137), Advice+GC: 161 mg/d (93, 229)] increased in both
intervention groups, compared with controls. At follow-up, no control women consumed >= 200mg/d of DHA
from fish, compared with 33% in the Advice arm (p=0.005) and 53% in the Advice+GC arm (p=0.0002). We did not
detect any differences in mercury intake or in biomarker levels of mercury and DHA between groups.
Conclusions: An educational intervention increased consumption of fish and DHA but not mercury. Future studies
are needed to determine intervention effects on pregnancy and childhood health outcomes.
Trial registration: Registered on clinicaltrials.gov as NCT01126762
Keywords: Fish, Pregnancy, Nutrition, Mercury, Omega-3 fatty acid, Docosahexaenoic acid (DHA)Introduction
In recent years, there has been active interest in reconcil-
ing the potential benefits and harms of prenatal fish con-
sumption to provide optimal fish consumption guidance
[1]. Fish, including finfish and other seafood, are the pri-
mary dietary source for elongated n-3 polyunsaturated
fatty acids (PUFA) [2]. Adequate intake of n-3 (also* Correspondence: emily_oken@hphc.org
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reproduction in any medium, provided the orknown as omega-3) PUFA, particularly docosahexaenoic
acid (DHA), is essential for optimal fetal neuro-
development, and may also protect against other adverse
perinatal and longer-term outcomes [3]. Fewer than half
of pregnant women in the US eat the 200 mg/day of
DHA recommended for optimal maternal and child
health [2-4].
However, fish also may be contaminated with methylmer-
cury, a ubiquitous toxicant present in all fish, especially
long-lived, predatory fish [5]. Approximately 10% of womentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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than the recommended level of 5.8 μg Hg/L in blood or 1.2
μg Hg/g in hair [5,6]. Some experts recommend an even
lower threshold of 3.5 μg Hg/L blood to provide maximal
protection against harm [7]. Because of the demonstrated
neurotoxicity of methylmercury and the particular suscepti-
bility of the developing brain even at low exposure levels
[8], the US Food and Drug Administration (FDA) and En-
vironmental Protection Agency (EPA) have issued warnings
recommending that pregnant women limit their fish con-
sumption and choose fish species that tend to have lower
levels of mercury [9]. Pregnant women, and other US
adults, consumed less fish after these guidelines were dis-
seminated [10,11].
The overall influence of fish – including its component
nutrients and toxicants – on maternal and child health out-
comes remains uncertain. While several observational stud-
ies have demonstrated improved mood among mothers
who ate more fish in pregnancy [12], and better neu-
rodevelopment among their children [13-19], these studies
are subject to confounding. Furthermore, large randomized
trials of omega-3 fatty acid supplements have not shown
benefits for these outcomes [20]. The discrepancy between
the benefits of fish intake implied by the observational stud-
ies and the null results from trials of supplements might be
explained by the many potential nutrient benefits of fish in
addition to n-3 PUFA, including vitamin D, iodine, and sel-
enium [2]. In fact, consumption of lean fish during preg-
nancy may provide as much if not greater benefit than fatty
fish for perinatal outcomes such as fetal growth [21-23]. Al-
ternatively, the inclusion criteria for supplement trials may
have been overly stringent, so that some individuals at risk
for adverse outcomes were already taking supplements, and
thereby excluded [24].
A randomized controlled trial optimizing fish con-
sumption is the most unbiased way to determine its im-
pact on improved maternal and child health outcomes.
However, it is yet not clear how best to promote fish
consumption during pregnancy without increasing mer-
cury exposure. The feasibility of such a nuanced public
health message is uncertain. Standard risk communica-
tion principles suggest that simple public health mes-
sages (“don’t smoke”) are most likely to achieve the
targeted behavior, but not all questions can be addressed
with such simple messages [1]. We therefore developed
and conducted a pilot randomized trial of advice to pro-
mote consumption of low-mercury, high-DHA fish. Our
goal was to determine if a nuanced public health mes-
sage (i.e. avoid high-mercury fish, but eat more low-
mercury fish) could be implemented successfully. We
hypothesized that, compared with controls, women ran-
domized to receive the intervention would increase their
intake of fish, and DHA from fish, without an increase
in mercury intake.Methods
Study design and population
In April-October 2010 we recruited women using post-
ings displayed at Boston-area obstetrics clinics, adver-
tisements in a local newspaper, online classified
advertisements, and local parenting listservs. The post-
ing identified the project as a study of “diet during preg-
nancy,” but did not mention fish. We provided a phone
number and e-mail address for interested women to
contact us. The Harvard Pilgrim Health Care Human
Subjects Committee approved all study protocols and
materials, and all procedures were in accord with the
Declaration of Helsinki.
A research assistant interviewed responders via tele-
phone to describe the study in detail, screen for eligibil-
ity, and collect demographic information. To be eligible
for participation, a woman had to be at least 18 years of
age, have a singleton pregnancy at <=22 weeks gestation,
and plan to remain in the Boston area through delivery.
Because we were interested in targeting women with low
fish and DHA intake, we included only women who
reported consuming fish up to 2 times per month, and
who had no contraindications to fish consumption such
as allergy, or self-restrictions such as vegetarian diet. So
that potential participants were not aware of the study’s
particular focus on fish, the screening questionnaire also
queried other components of diet including intake of
fruits and vegetables, dairy, nuts, and meat.
Of 288 respondents (Figure 1), 215 did not meet inclu-
sion criteria, most often because they reported consum-
ing fish more than twice per month (n=155, 72%) or
were already at least 22 weeks gestation (n=34, 16%).
Only 4 women declined participation, and another 8
subsequently became ineligible (by failing to schedule
the baseline study visit before 23 weeks gestation, having
a miscarriage, or learning of a twin gestation). We
conducted baseline visits at 12–22 weeks gestation with
61 women. One woman disenrolled after randomization,
but before study recruitment was complete, and there-
fore we increased our targeted sample size from 60 to
61. Subsequently 4 women were lost to follow-up, and
one died. Therefore, we obtained baseline and follow-up
information on 55 women.
Baseline measures and randomization
At the baseline study visit, which we conducted in our
research offices in Boston or at the participants’ home
or office, the research assistant obtained written in-
formed consent and administered an interview to collect
information on pregnancy history, health, and socio-
demographic characteristics. Participants completed an
Edinburgh Postpartum Depression Scale (EPDS) [25].
We queried the type, dose, and frequency of supple-
ments taken. We collected blood by venipuncture.
Figure 1 Flow diagram of Food for Thought participants from recruitment to 12-week follow-up.
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ied intake of 25 specified types of finfish and 11 types of
shellfish/bivalves. We based our instrument on one used
in the National Health and Nutrition Examination Sur-
vey (NHANES) [6,26,27], and we also included an add-
itional 4 fish types likely to be consumed in our
geographic area, based on our preliminary research [28].
We asked women to report the number of times they
had eaten each of the 36 fish types during the previous
30 days. In addition, because the NHANES instrument
did not obtain information on serving size, we also asked
women to report the number of ounces per serving of
each type for which they reported any consumption. We
provided reference food models for 1 and 3-ounce serv-
ing sizes to support accurate reporting. We asked
women who had reported consumption of canned tuna
whether they had eaten white, chunk light, or both.
We also assessed general diet using PrimeScreen, a
brief validated [29] food frequency questionnaire (FFQ)
that includes 21 questions on diet during the past 30
days, including 4 questions on intake of “Canned tuna
fish,” “Dark meat fish, for example mackerel, salmon,
sardines, bluefish, or swordfish,” “Other fish, for example
cod, haddock, or halibut,” and “Shrimp, lobster, scallops,
or clams as a main dish.” Six response categories ranged
from “never” to “nearly daily or daily.” These questions
were similar to those used in a comprehensive semi-
quantitative FFQ that has been extensively validated inpregnant and non-pregnant adults, and used to examine
associations of dietary fish and elongated n-3 PUFA in-
take with a large number of health outcomes (e.g.
[4,14,30-34]).
We prepared sealed opaque envelopes in which we in-
cluded study intervention materials for each of the 3
arms, and subsequently ordered them using a random
number table. After all baseline measures were collected,
the research assistant opened the next sequentially num-
bered envelope, and spent approximately 30 minutes
reviewing the contents with each participant, answering
all questions. At the completion of the visit, we provided
all women with a $25 gift card and a fabric shopping bag
with the study logo.
For women randomized to the two intervention arms,
we provided an 8-page booklet that summarized the
health effects of DHA in pregnancy, encouraged fish in-
take, and included a list of 29 recommended low-
mercury fish sorted according to DHA content (Figure 2).
The booklet also included information on which fish
to avoid to minimize exposure to mercury and other
contaminants, based on advice from the US federal gov-
ernment [35] and Massachusetts Department of Envi-
ronmental Protection (Figure 2). We also provided a
shopping list notepad that included the list of
recommended low-mercury fish ranked by their DHA
content and 2 copies of a wallet-sized card summarizing
the information in the brochure. We encouraged women
Figure 2 List of fish types provided to participants in the
Advice and Advice+Gift Card arms.
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member who purchased food. We prepared these mate-
rials based on our preliminary qualitative research [28],
targeted at a 5th grade reading level, and pilot tested
them prior to use with Boston-area pregnant women not
enrolled in the trial.
Each week thereafter during the 12 week-long interven-
tion, we emailed women in the intervention groups a
“Weekly Thoughts” email, in which we encouraged con-
sumption of 2 weekly fish servings, included a tip on the
health benefits of fish or DHA, provided a recipe to prepare
one of the fish types recommended in our brochure, and
included a website address for more information.
Women randomized to the Advice + Gift Card arm
also received a $40 Whole Foods gift card at the baseline
visit, and we mailed them an additional gift card each of
the 2 subsequent months, for a total of $120 ($10/week).
We encouraged the women to use the gift cards to
purchase fish.We provided women randomized to the control arm
with a 7-page “Pregnancy Food Guide” and 1-page list of
“Food Don’ts,” both materials commonly given to
women receiving prenatal care at local obstetric prac-
tices. These materials provided advice on a variety of nu-
tritional topics for pregnant women, including advice
based on the 2004 US governmental mercury advisory
for pregnant women [35], to avoid the 4 fish types
highest in mercury, and eat up to 12 ounces a week of a
variety of fish and shellfish that are lower in mercury.
After the baseline visit, we sent control women weekly
emails with tips on general pregnancy health and rec-
ipes, not focused on fish.
Follow-up measures
At the end of the 12-week intervention period we held an
in-person follow-up visit (at a mean of 30 weeks gestation),
at which participants completed self-administered ques-
tionnaires that included many of the same questions ad-
ministered at baseline, including the same fish intake recall,
use of DHA supplements and supplemented foods, and the
EPDS. The follow-up questionnaire also included a series of
questions about women’s opinions and attitudes regarding
fish consumption, with 4-point Likert response scales ran-
ging from “strongly disagree” to “strongly agree.” We asked
women to report what they believed the focus of the study
to have been, and coded the unstructured responses to in-
dicate whether the woman mentioned fish or not. We again
collected blood and also obtained a full-length sample of
hair (“matchstick-thickness”) from the occipital scalp.
We provided an additional $25 gift card to all partici-
pants at the completion of the follow-up visit. About 2
weeks after the woman’s due date, we administered a
brief questionnaire via telephone, mail, or email, to col-
lect information on pregnancy duration and birth out-
comes. We obtained post-delivery data from 48 of the
55 women who attended the follow-up visit.
Biosample storage and assay
We refrigerated all blood samples immediately after col-
lection, and processed and stored them at −80°C within
24 hours. We collected and stored whole blood in trace
element-free tubes for mercury assay. We stored hair
tied at the proximal end in paper envelopes at room
temperature. We measured total mercury in whole
blood and hair using the Direct Mercury Analyzer 80
(Milestone Inc., Monroe, CT). We analyzed the pro-
ximal 3 cm of hair, which reflects mercury deposited
approximately 30–120 days prior to collection (the
most recent 30 days’ growth remains below the scalp).
Using standard samples, the Relative Standard Devi-
ation (RSD) was 6.2% for blood (interlaboratory study
program INSPQ, Laboratoire de Toxicologie, Quebec),
and 2.4% for hair (Homogenized powdered hair,
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Langfang, China). We detected Hg concentrations
as low as 0.3 mcg/g with a minimum sample weight
of 0.2 g.
We collected whole blood in lithium heparin tubes,
centrifuged it at 2,000 rpm at 4°C for 10 minutes, and
stored plasma for fatty acid assay. Fatty acids were
extracted and quantified in a single run using gas–liquid
chromatography on a fused silica capillary cis/trans col-
umn (SP2560, Supelco Inc, Belefonte, PA) [35]. Peak
retention times and area percent of total fatty acids
were identified from 40 peaks by injecting standards
(NuCheck Prep, Elysium, MN), using Agilent Technolo-
gies ChemStation A.08.03 software for analysis. With
this method, the minimum reliable normalized percent
area is 0.05%, and the within-run CV for DHA was 4.1%.
Estimation of dietary fatty acid and mercury intake
We estimated daily intake of DHA from supplements
based upon the dose and frequency of consumption. If
the woman provided information on the brand of sup-
plement but not the exact dose, we obtained DHA con-
centration from the manufacturer. For women (n=5) for
whom we had information on DHA supplement fre-
quency but not dose or brand, we assigned the median
value of supplement DHA reported in the study popula-
tion (200 mg/dose). For each of the 2 methods of dietary
assessment, we calculated daily intake of DHA (mg/day)
and mercury (mcg/day) from fish as detailed below. We
also calculated intake of mercury per kg body weight per
day. Within one week after the study visit, we contacted
women with estimated mercury intake above the EPA
reference dose of 0.1 mcg/kg body weight/day. We made
specific recommendations to reduce their mercury in-
take based on their dietary report.
To assign a DHA concentration to each fish type in-
cluded in the fish questionnaire, we used the USDA Nu-
trient database [36]. For mercury, we used data provided
by the FDA [37], or from a publication by Groth [38] for
fish types not included on the FDA website. We multi-
plied the number of servings by the reported serving size
for each fish type, and summed intake across all fish
consumed to estimate total daily DHA and mercury in-
take from fish. In our analysis, we defined low-mercury,
high-DHA fish as those containing >400 mg DHA/
100 mg of fish and <0.1 mcg Hg/g of fish, which in-
cluded salmon, whitefish, herring, anchovies, trout,
mackerel, sardines, mussles, pollock, and saltcod. We
defined higher-mercury fish as those containing ≥0.1
mcg Hg/g fish, which included lobster, tuna, swordfish,
shark, seabass, porgy, perch, and bass.
For the 4 PrimeScreen questions on fish, we applied
weightings for the different fish types included in each
of the 4 groups, based on the study participants’ eatinghabits from the 36-item questionnaire results. For ex-
ample, “dark meat fish” was 20% anchovies, 1% mack-
erel, 64% salmon, 14% sardines, and 1% trout. We
assumed a 113 g (4 ounce) serving size for each of the
groups, based on the response categories used in the
parent SFFQ from which we derived our instrument
[39,40]. For each serving, we assigned concentrations of
DHA (460 mg for canned tuna, 1406 mg for dark fish,
313 mg for other fish, and 232 mg for shellfish) and
mercury (25.8 mcg for canned tuna, 2.2 mcg for dark
fish, 4.8 mcg for other fish, and 2.4 mcg for shellfish.
Blinding
All study staff and participants were blinded to group as-
signment before baseline measures were collected. To
minimize bias introduced by non-blinding of the single
research assistant, who both delivered the intervention
and collected follow-up data, all follow-up self-reported
data were collected by self-administered questionnaire
rather than by interview. Laboratory staff, statistical ana-
lysts, and study investigators remained blinded to group
assignment throughout data collection and analysis.
Data analysis
We performed an intention to treat analysis including all
women on whom we obtained data at the follow-up visit.
We used 1-way ANOVA analyses to compare differences
in change from baseline to followup within each of the 2
intervention groups vs. the control group for the dietary
and blood measures of fish, fatty acid, and mercury in-
take. We also compared hair mercury at follow-up in the
intervention groups vs. the control group using the same
method. We used Fisher’s exact analysis to compare dif-
ferences in dichotomous (clinical) outcomes in the 2
intervention groups vs. the control group. Our primary
analyses were unadjusted; additional adjustment for
baseline characteristics and gestational age at baseline or
follow-up did not change results, and therefore we
present unadjusted results only. We performed all ana-
lyses using SAS Version 9.3 (Cary, NC).
Results
Maternal age (mean 30.2 [SD 5.6] years), pre-pregnancy
BMI (25.6 [6.1] kg/m2), and other characteristics did not
differ among groups at baseline (Table 1), although the
proportion of women working full-time was somewhat
higher in the Advice + Gift Card group (50%) than in the
other two groups (35%). Estimated mean (range) intakes
of fish [21 (0–125) g/day], DHA from fish [91 (0–554)
mg/d], and mercury from fish [1.4 (0–8.5) mcg/day],
were not different across the 3 arms (Table 1), although
DHA intake from fish was somewhat higher in the Ad-
vice group (mean 132 mg/day) than in the Advice + Gift
Card (79 mg/day) and control (63 mg/day) women.
Table 1 Baseline characteristics of 55 women enrolled in the Food for Thought study, by study arm
Characteristics Total (N=55) Control (N=20) Advice (N=18) Advice + Gift Card (N=17)
Median (IQR) or N (%)
Age (y) 30.9 (25.6, 33.8) 32.4 (27.7, 34.3) 32.6 (27.9, 35.9) 27.6 (24.5, 32.0)
Gestational age (wks) 16.1 (13.3, 20.7) 19.1 (14.7, 21.0) 15.2 (13.0, 18.6) 16.4 (13.9, 21.0)
Pre-pregnancy BMI (kg/m2) 23.4 (21.1, 28.3) 22.3 (21.1, 27.0) 25.8 (22.8, 34.5) 23.4 (20.7, 28.3)
Single 11 (20%) 4 (20%) 3 (17%) 4 (24%)
First pregnancy 16 (29%) 6 (30%) 6 (35%) 4 (22%)
Race/ethnicity
White 27 (49%) 9 (45%) 9 (50%) 9 (53%)
Black 6 (11%) 2 (10%) 2 (11%) 2 (12%)
Asian 6 (11%) 3 (15%) 2 (11%) 1 (6%)
Hispanic/other 16 (29%) 6 (30%) 5 (28%) 5 (29%)
Working full time 22 (40%) 7 (35%) 6 (35%) 9 (50%)
Never smoker 40 (73%) 14 (70%) 14 (78%) 12 (71%)
Supplements
DHA from supplements, all (mg/day) 0 (0, 200) 0 (0, 160) 0 (0, 200) 0 (0, 180)
DHA from supplements, takers* (mg/day) 200 (200, 275) 238 (200, 315) 200 (200, 200) 200 (180, 200)
Diet
Fish intake (g/day) 11 (4, 23) 10 (4, 18) 15 (2, 37) 10 (7, 23)
DHA intake from fish (mg/day) 41 (11, 113) 40 (11, 63) 75 (6, 203) 40 (32, 111)
DHA from diet > 200 mg/day (%) 8 (15%) 1 (5%) 5 (28%) 2 (12%)
Total DHA diet + supplements (mg/day) 113 (36, 238) 62 (37, 203) 200 (24, 356) 116 (54, 235)
Mercury intake from fish (mcg/day) 0.6 (0.1, 2.0) 0.3 (0.1, 2.1) 0.7 (0.0, 1.8) 0.6 (0.2, 1.5)
Mercury intake (mcg/kg/day) 0.01 (0.00, 0.03) 0.01 (0.00, 0.03) 0.01 (0.00, 0.03) 0.01 (0.00, 0.02)
Biomarkers
Plasma DHA (% of total fatty acids) 1.9 (1.5, 2.3) 1.8 (1.5, 2.2) 2.1 (1.8, 2.4) 1.8 (1.6, 2.2)
Whole blood mercury (mcg/L) 1.0 (0.7, 1.7) 1.1 (0.8, 1.5) 0.9 (0.6, 2.0) 0.9 (0.8, 1.9)
Whole blood mercury > 3.5 mcg/L† (%) 4 (7%) 1 (5%) 1 (6%) 2 (12%)
*Among those taking supplements (n=6 in each of the 3 arms). †Threshold per Mahaffey et al., 2009 [7].
IQR = interquartile range.
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supplements, plasma DHA concentration, or whole
blood mercury levels across the 3 groups (Table 1).
Primary outcomes
At the follow-up visit there were substantial differences
in dietary intake between intervention and control par-
ticipants (Table 2). At follow-up, no control women con-
sumed the recommended 200mg/d of DHA from fish,
compared with 33% of women in the Advice group
(p=0.005) and 53% of women in the Advice+GC group
(p=0.0002). Over the 12 week intervention period, intake
of fish increased in the Advice + Gift Card (+165 g/day)
and Advice (+99 g/day) arms, but hardly changed in the
control arm (+13 g/day). Intake of DHA from fish ac-
cordingly increased from baseline in the intervention
arms (Advice + Gift Card: +148 mg/day, Advice: +63 g/
day), but actually decreased a bit among control women(−11 mg/day). In contrast, DHA intake from supplements
remained essentially stable in all 3 groups (Table 2).
Compared with the control group, women in the Ad-
vice + Gift Card group had significant increases over the
duration of the study in intake of fish (22 g/day, 95% CI: 5,
39) and DHA from fish (161mg/day, 95% CI: 93, 229)
(Figure 3). Women in the Advice-only arm had a some-
what smaller increase in intake of fish (12 g/day, 95% CI: -
5, 29), but still a significantly increased intake of DHA
(70 mg/day, 95% CI: 3, 137), compared with controls
(Figure 3). Almost half of the increase in fish intake was at-
tributable to an increase in the types we identified as low-
mercury, high-DHA fish (Advice + Gift Card: 10 g/day,
95% CI: 5, 15; Advice: 5 g/day, 95% CI: 0.3, 10). We ob-
served no differences in intake of higher mercury fish (Ad-
vice+ Gift Card: -0.5 g/day, 95% CI: -7, 6; Advice:-4 g/day,
95% CI: -10, 2). Despite the differences in estimated fish
and DHA intake, we did not observe any difference vs.
Table 2 Change from baseline to follow-up in intake and biomarker levels of fish, docosahexaenoic acid (DHA), and
mercury, and hair mercury collected at follow-up, by study arm, among 55 pregnant women enrolled in the Food for
Thought study








Advice + Gift Card vs.
Control
Mean (SD) or % P value*
Supplements
DHA from supplements (mg/day) 10 (80) 10 (52) 34 (76) 0.99 0.31
Diet
Fish intake (g/day) 2 (17) 14 (22) 24 (36) 0.15 0.01
DHA from fish (mg/day) −12 (75) 57 (114) 149 (118) 0.04 <0.0001
DHA from fish + supplements (mg/
day)
2 (11) 67 (130) 183 (144) 0.10 <0.0001
Mercury intake from fish (mcg/day) 0.4 (1.8) −0.1 (2.1) 0.9 (1.8) 0.37 0.50
Mercury intake from fish (mcg/kg/
day)
0.007 (0.03) −0.003 (0.02) 0.012 (0.03) 0.27 0.55
Biomarkers
Plasma DHA (% of total fatty acids) 0.01 (0.45) −0.12 (0.66) −0.07 (0.29) 0.03 0.52
Whole blood mercury (mcg/L) 0.35 (1.12) −0.26 (0.36) −0.40 (1.27) 0.67 0.22
Follow-up
Hair mercury (mcg/g) 0.31 (0.31) 0.25 (0.23) 0.31 (0.30) 0.50 0.99
* P value from 1-way ANOVA.
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(Table 2) or n-3 eicosapentaenoic acid (Advice: -0.18%,
95% CI: -0.37, 0.01; Advice+ Gift Card: -0.14, 95%
CI: -0.33, 0.05).
Intake of mercury from fish did not change substan-
tially in any group (Table 2), and there were no material
differences in change from baseline to follow-up be-
tween intervention and control women (Figure 3). Also,
there were no differences between groups in hair mer-
cury concentrations at follow-up, or in change from
baseline to follow-up in blood mercury (Table 2).
Changes in intake of fish, DHA from fish, and mercury
from fish were similar in magnitude and significance
when we used measures derived from the 4-question
FFQ, rather than from the 36-item detailed fish ques-
tionnaire (data not shown).Process measures
There were substantial differences between study arms in
fish consumption attitudes assessed at the follow up visit.
Compared with women randomized to the control group,
women randomized to the two intervention groups were
substantially more likely to strongly agree that they “enjoy
eating fish” (40% vs. 10%, p=0.02), that “fish contains nutri-
ents that are healthy for my baby” (74% vs. 35%, p=0.004),
and that “some kinds of fish are better for me to eat than
other kinds” (83% vs. 55%, p=0.03). Intervention women
were more likely to strongly disagree that “I try NOT to eat
fish because it might be harmful for me or my baby” (63%vs. 35%, p=0.05). There were no differences in attitudes
about the expense of fish, the convenience of eating fish, or
knowledge of how to prepare fish (data not shown).
Intervention women were somewhat less likely to re-
port that their obstetrician had provided them with writ-
ten information about fish intake during pregnancy (37%
vs. 60%, p=0.10) or had discussed fish intake with them
(31 vs. 55%, p=0.09) during the index pregnancy. There
was no difference in consumption of foods with added
DHA (49% intervention, 35% control, p=0.33).
When asked post-delivery what they believed to have
been the purpose of the study, all but two of the inter-
vention women reported that the focus had been fish,
seafood, DHA, or omega-3 fatty acids; the remaining
two women reported that the focus was on diet or eating
habits but did not mention fish. Only one control
woman mentioned fish; the remainder thought the study
was about diet during pregnancy in general. Among the
17 women randomized to the Advice +Gift Card group,
only 2 reported not having used the gift cards to pur-
chase fish; one commented “I’m not a fish person” and
the other that the fish was “too expensive.”
Safety and pregnancy outcomes
Five women had estimated mercury intake above the EPA
reference dose: two women (in the Advice arm) at the base-
line visit only, one woman (in the control arm) at the
follow-up visit only, and two women (one in the Advice
arm and one in the Advice + Gift Card arm) at both base-




Figure 3 Changes from baseline to follow-up among Advice
and Advice +Gift Card vs. control participants in the Food for
Thought study, for intake of fish (3a), docosahexaenoic acid
(DHA) (3b), and mercury (3c).
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had whole blood mercury above 3.5 mcg/L at baseline and
two at follow-up and there was no difference between treat-
ment groups at either timepoint. One woman randomized
to the Advice arm died during the intervention period; her
partner reported that the death was related to her pre-
pregnancy health, but did not provide an exact cause of
death. One infant of a mother who was randomized to the
Advice arm was stillborn.Among the 48 women from whom we obtained post-
delivery information, we observed no differences by
intervention arm in rates of gestational diabetes mellitus,
pre-eclampsia, gestational hypertension, induction of
labor, cesarean delivery, or postpartum depressive symp-
toms (data not shown). However, there was a suggestion
of a lower rate of preterm delivery (<37 completed
weeks gestation) among intervention vs. control women
(0/31 vs. 2/17 [12%] p=0.12).
Discussion
In this pilot randomized controlled trial, we found that
an educational intervention resulted in increased intake
of low-mercury, high-DHA fish among pregnant women
with low fish consumption at baseline. Women random-
ized to the intervention had significantly and substan-
tially greater intake of DHA, but no greater mercury
intake. There were no differences in use of DHA supple-
ments, which we did not target in our intervention.
Process measures suggested that women in the interven-
tion groups absorbed the study’s messages and devel-
oped more positive attitudes about the health effects of
fish. Women in the control group were effectively
blinded to the study’s focus on fish.
This pilot study was not powered to examine clinical
outcomes, and accordingly there were no differences in
most studied pregnancy outcomes. However, we found
some evidence for a decrease in preterm birth among
intervention vs. control women, although this difference
was not significant in this small sample. Prolongation of
gestation with attendant reduction in rates of preterm
birth is one of the most consistent findings of prior ob-
servational studies of fish intake as well as intervention
studies of n-3 PUFA supplements during pregnancy
[24]. This finding will need to be followed-up in a larger
trial of fish consumption advice. While we observed two
deaths (one stillbirth and one maternal death) in the Ad-
vice arm, we have no reason to believe these deaths were
related to the study’s intervention messages. However,
this finding will also merit additional evaluation in a lar-
ger trial.
Although we observed differences in estimated intake
of DHA, we did not detect an increase in plasma DHA
concentration among intervention vs. control arms. In
fact, plasma DHA, which normally decreases throughout
pregnancy, actually decreased more among women in
the Advice arm compared with controls, even though
reported intake of DHA was greater in the Advice arm.
We anticipated that plasma concentrations would be
more sensitive to short-term changes in diet than con-
centrations in erythrocytes, which survive for an average
of 120 days. However, it is possible that plasma is not
sufficiently sensitive to dietary change. Alternatively, be-
cause intervention women became aware of the study’s
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reporting bias.
There are several limitations to this study. All women re-
sided in the greater Boston, MA area, and thus results may
not be generalizable to women living elsewhere with differ-
ent access to fish. However, the population was of diverse
racial/ethnic and socio-economic makeup. By design we
limited recruitment to low fish consumers, i.e. women who
reported intake of <= 2 monthly fish servings. Nevertheless,
estimates of daily intake of fish, DHA, and mercury in our
study were similar to those among women of childbearing
age in the nationally representative US National Health and
Nutrition Examination Survey (NHANES) [2,6]. Also, mean
blood mercury in our population (1.4 mcg/L) was similar to
that in NHANES (geometric mean 0.8 mcg/L) [6], and
plasma DHA concentration (1.9%) was similar to that in a
large cohort of pregnant women also from Boston (1.9%)
[14]. Thus, even though our population had similar esti-
mated fish consumption to reference populations not se-
lected on the basis of fish intake, we still observed effects of
the intervention messages on intake. Follow-up after 12
weeks might not have been long enough to allow detectable
changes in biomarkers. However, prior studies have
detected changes in plasma DHA [41,42] and blood mer-
cury [43] within 8 weeks following dietary interventions to
increase n-3 PUFA or reduce mercury intake.
We designed the intervention brochure to be adminis-
tered in the context of a research study, and the research
assistant reviewed all of the intervention messages with
the participants at an in-person visit. However, as the
materials were targeted towards a low literacy level, it is
possible that these materials might also be effective at
increasing consumption of low-mercury, high-DHA fish
in a clinical or public health setting. Intervention women
randomized to receive grocery store gift cards reported
using these gift cards to buy fish, and had higher fish
and DHA intake compared with women who received
the educational intervention alone. While such an incen-
tive is not feasible for a public health campaign, future
research studies might consider providing a similar in-
centive to maximize contrast between study groups.
Conclusions
Despite the promise of marine n-3 PUFA in improving
perinatal health outcomes and child development, ran-
domized trials of supplements have generally not sup-
ported the positive findings of observational studies of
fish consumption. Because the type and frequency of fish
consumed tends to vary with factors such as maternal
age, race/ethnicity, and place of residence [7], factors
that might independently be associated with offspring
development or other relevant outcomes, it is possible
that sociodemographic confounding underlies the observed
benefits seen in previous cohort studies. Alternatively, it ispossible that consumption of fish, rather than supplements,
is necessary to improve maternal and child health out-
comes. Some have been reluctant to encourage pregnant
women to consume fish regularly because of concern that
they may exceed recommended intake of mercury. In this
pilot study, however, we demonstrated that it is possible to
promote consumption of fish that is low in mercury and
high in DHA among pregnant women who are infrequent
fish consumers. A larger study with longer-term follow up
will be needed to demonstrate whether these differences in
intake improve maternal and child health outcomes.
Perhaps the major potential confounder in previous re-
search into the health effects of fish intake is the increased
methylmercury intake that may occur from greater con-
sumption of fish, especially larger or predatory fish. The ad-
verse effects of methylmercury would tend to mitigate any
benefits of fish consumption for outcomes important to
population health including offspring neurodevelopment
and adult cardiovascular disease [19]. Our study demon-
strates that a nuanced public health message can be
implemented to effect beneficial changes in diet. We have
found that an intervention to increase fish consumption,
when carefully directed toward fish with low mercury con-
tent, is feasible, setting the stage for future research into the
health effects of fish consumption that will not be con-
founded by mercury exposure.
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